These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
523 related items for PubMed ID: 15902631
1. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period]. Kuhl CK, Schrading S, Weigel S, Nüssle-Kügele K, Sittek H, Arand B, Morakkabati N, Leutner C, Tombach B, Nordhoff D, Perlet C, Rieber A, Heindel W, Brambs HJ, Schild H. Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631 [Abstract] [Full Text] [Related]
2. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH. J Clin Oncol; 2010 Mar 20; 28(9):1450-7. PubMed ID: 20177029 [Abstract] [Full Text] [Related]
3. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. Podo F, Sardanelli F, Canese R, D'Agnolo G, Natali PG, Crecco M, Grandinetti ML, Musumeci R, Trecate G, Bergonzi S, De Simone T, Costa C, Pasini B, Manuokian S, Spatti GB, Vergnaghi D, Morassut S, Boiocchi M, Dolcetti R, Viel A, De Giacomi C, Veronesi A, Coran F, Silingardi V, Turchett D, Cortesi L, De Santis M, Federico M, Romagnoli R, Ferrari S, Bevilacqua G, Bartolozzi C, Caligo MA, Cilotti A, Marini C, Cirillo S, Marra V, Martincich L, Contegiacomo A, Pensabene M, Capuano I, Burgazzi GB, Petrillo A, Bonomo L, Carriero A, Mariani-Costantini R, Battista P, Cama A, Palca G, Di Maggio C, D'Andrea E, Bazzocchi M, Francescutti GE, Zuiani C, Londero V, Zunnui I, Gustavino C, Centurioni MG, Iozzelli A, Panizza P, Del Maschio A. J Exp Clin Cancer Res; 2002 Sep 20; 21(3 Suppl):115-24. PubMed ID: 12585665 [Abstract] [Full Text] [Related]
4. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Riedl CC, Ponhold L, Flöry D, Weber M, Kroiss R, Wagner T, Fuchsjäger M, Helbich TH. Clin Cancer Res; 2007 Oct 15; 13(20):6144-52. PubMed ID: 17947480 [Abstract] [Full Text] [Related]
5. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH. J Clin Oncol; 2005 Nov 20; 23(33):8469-76. PubMed ID: 16293877 [Abstract] [Full Text] [Related]
6. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Schelfout K, Van Goethem M, Kersschot E, Colpaert C, Schelfhout AM, Leyman P, Verslegers I, Biltjes I, Van Den Haute J, Gillardin JP, Tjalma W, Van Der Auwera JC, Buytaert P, De Schepper A. Eur J Surg Oncol; 2004 Jun 20; 30(5):501-7. PubMed ID: 15135477 [Abstract] [Full Text] [Related]
7. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound. Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R. Invest Radiol; 2009 Jul 20; 44(7):412-21. PubMed ID: 19448554 [Abstract] [Full Text] [Related]
8. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). Kuhl CK. J Exp Clin Cancer Res; 2002 Sep 20; 21(3 Suppl):103-6. PubMed ID: 12585663 [Abstract] [Full Text] [Related]
9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, Klijn JG, Dutch MRI Screening (MRISC) Study Group. Cancer; 2006 Jun 01; 106(11):2318-26. PubMed ID: 16615112 [Abstract] [Full Text] [Related]
11. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O'Loughlin M, Harms S, Bluemke DA, International Breast MRI Consortium Working Group. Cancer; 2005 May 01; 103(9):1898-905. PubMed ID: 15800894 [Abstract] [Full Text] [Related]
16. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study. Bollet MA, Thibault F, Bouillon K, Meunier M, Sigal-Zafrani B, Savignoni A, Diéras V, Nos C, Salmon R, Fourquet A, Institut Curie Breast Cancer Study Group. Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):13-8. PubMed ID: 17449193 [Abstract] [Full Text] [Related]
18. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study. Warner E, Causer PA, Wong JW, Wright FC, Jong RA, Hill KA, Messner SJ, Yaffe MJ, Narod SA, Plewes DB. Breast J; 2011 Sep 01; 17(1):9-17. PubMed ID: 21251121 [Abstract] [Full Text] [Related]